Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediHerb is a premier Australian herbal medicine company that specializes in the development and manufacture of pharmaceutical-grade phytotherapeutic products. Founded in 1986 by Associate Professor Kerry Bone, the company is recognized globally for its commitment to scientific research and rigorous quality control standards, often referred to as Phytotherapeutic quality. MediHerb produces a wide range of liquid extracts and tablets that are primarily distributed to healthcare professionals to support various therapeutic areas, including immune function, hormonal balance, and cognitive health. The company operates a state-of-the-art manufacturing facility in Warwick, Queensland, which is TGA-certified and employs advanced analytical techniques like High-Performance Liquid Chromatography to ensure product potency. Currently a flagship brand of Integria Healthcare, MediHerb maintains a significant international footprint through strategic partnerships, most notably with Standard Process in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MediHerb Trading.